Gossamer Bio Inc (GOSS): Next-Year EPS Estimate 75.55%
As of 2026-06-04, Gossamer Bio Inc (GOSS) has a next-year EPS growth estimate of 75.55%.
On 2026-05-26, analyst consensus for GOSS's next-year EPS growth shifted from 72.63% to 75.55% — a positive change of 2.92 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions. Current-year growth is projected at 41.10%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 75.55%
- EPS growth this year
- 41.10%
- EPS next quarter (est)
- -$0.12
- Last price
- $0.18
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 75.55% | 41.10% | -$0.12 | $0.18 |
| 2026-06-03 | 75.55% | 41.10% | -$0.12 | $0.19 |
| 2026-06-02 | 75.55% | 41.10% | -$0.12 | $0.20 |
| 2026-06-01 | 75.55% | 41.10% | -$0.12 | $0.20 |
| 2026-05-31 | 75.55% | 41.10% | -$0.12 | $0.23 |
| 2026-05-28 | 75.55% | 41.10% | -$0.12 | $0.21 |
| 2026-05-27 | 75.55% | 41.10% | -$0.12 | $0.22 |
| 2026-05-26 | 75.55% | 41.10% | -$0.12 | $0.22 |
| 2026-05-25 | 72.63% | 45.30% | -$0.12 | $0.21 |
| 2026-05-24 | 72.63% | 45.30% | -$0.12 | $0.21 |
| 2026-05-21 | 72.63% | 45.30% | -$0.12 | $0.20 |
| 2026-05-20 | 68.81% | 44.63% | -$0.11 | $0.22 |
| 2026-05-19 | 68.04% | 45.97% | -$0.11 | $0.20 |
| 2026-05-18 | 67.08% | 41.98% | -$0.11 | $0.19 |
| 2026-05-17 | 63.58% | 39.32% | -$0.17 | $0.34 |
| 2026-05-14 | 63.58% | 39.32% | -$0.17 | $0.33 |
| 2026-05-13 | 63.46% | 39.33% | -$0.17 | $0.35 |
| 2026-05-12 | 63.46% | 39.33% | -$0.17 | $0.34 |
| 2026-05-11 | 63.46% | 39.33% | -$0.17 | $0.34 |
| 2026-05-10 | 63.46% | 39.33% | -$0.17 | $0.33 |
| 2026-05-07 | 68.59% | 38.22% | -$0.17 | $0.34 |
| 2026-05-06 | 68.59% | 38.22% | -$0.17 | $0.35 |
| 2026-05-05 | 68.59% | 38.22% | -$0.17 | $0.34 |
| 2026-05-04 | 68.59% | 38.22% | -$0.17 | $0.35 |
| 2026-05-03 | 68.59% | 38.22% | -$0.17 | $0.37 |
| 2026-04-30 | 68.59% | 38.22% | -$0.17 | $0.37 |
| 2026-04-29 | 68.59% | 38.22% | -$0.17 | $0.35 |
| 2026-04-28 | 68.59% | 38.22% | -$0.17 | $0.34 |
| 2026-04-27 | 68.59% | 38.22% | -$0.17 | $0.35 |
| 2026-04-26 | 68.59% | 38.22% | -$0.17 | $0.36 |
Recent News
- Gossamer Bio Shares Decline After Wider-Than-Expected Q1 Loss Despite Revenue Beat (GOSS)InvestorsHub
- Gossamer Bio Shares Decline After Wider-Than-Expected Q1 Loss Despite Revenue Beat (GOSS)InvestorsHub
- Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder SupportBusiness Wire
- Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder SupportBusiness Wire
- Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business UpdateBusiness Wire
- Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business UpdateBusiness Wire
- Gossamer Bio: Q1 Earnings SnapshotAssociated Press
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Gossamer Bio Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Gossamer Bio Inc (GOSS) has a next-year EPS growth estimate of 75.55%, based on analyst consensus.
When was the latest EPS estimate revision for GOSS?▾
The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 72.63% to 75.55%.
What sector and industry does Gossamer Bio Inc belong to?▾
Gossamer Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GOSS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Gossamer Bio Inc (GOSS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports